Close
CDMO Safety Testing 2026
Novotech

Vetter Earns Frost & Sullivan’s Customer Value Award for the Third Time

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...
- Advertisement -

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has been awarded the Frost & Sullivanโ€™s 2023 Global Customer Value Leadership Award in the aseptic fill-and-finish market for the companyโ€™s high performance for its customers. The award, presented annually by the international growth strategy consulting firm, focuses on both business and customer impact along with industry status and trends in the market. In previous years the CDMO was awarded for their Customer Value Leadership and for their Customer Service Leadership.

Frost & Sullivan recognizes the companies that offer products or services customers find superior for the overall price, performance, and quality. The firm applies a rigorous analytical process to evaluate multiple nominees for each award category before determining the final recipient. The process involves a detailed evaluation of best practices criteria across the two dimensions โ€“ business and customer โ€“ for each nominated company.

Vetterโ€™s core service offerings include drug product development, clinical and commercial aseptic filling, device assembly and secondary packaging. The award details Vetterโ€™s consistent and successful efforts to put the customer at the center of its operations.

In response to the announcement, Frost & Sullivanโ€™s Senior Industry Analyst Surbhi Gupta said, โ€œVetter offers highly specialized, state-of-the-art parenteral development and manufacturing expertise for the entire life cycle, from clinical development to commercial production and packaging. Through unwavering dedication to delivering the highest quality products and services and their exceptional knowledge and expertise, they strive to ensure their customers receive the best possible services.โ€

Additionally, Frost & Sullivanโ€™s Best Practices Research Analyst Pavel Zhebrouski remarked, โ€œIn 2021, we recognized Vetter for its business and customer impact, and we remain impressed with the continuous innovation and sustained leadership. Vetter uniquely leverages its expertise to meet its customersโ€™ needs, particularly the growing transition to injectables.โ€

Vetter Managing Director Peter Soelkner was proud of the industry recognition: โ€œWe always make our best efforts to provide customers with qualities that are highlighted in this prestigious award. We leverage our seven decades of experience and over 6,000 employees to do so.โ€

Managing Director fellow Thomas Otto emphasized: โ€œWe graciously acknowledge that this award shows we are on the right path, and we are looking to continue this approach towards the future.โ€

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

FUJIFILM Corporation has developed a new screening methodology aimed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป